No-PCR library preparation. During Illumina library preparation, sample DNA is fragmented, end-repaired and A-tailed. Adapters, essentially consisting of the sequencing primer–annealing ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein ...

It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in genomic sequencing and analysis, today announced it is collaborating with NVIDIA to advance technology platforms for the analysis and ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy ...

Element Biosciences said Wednesday it raised $277 million in a Series D financing round, giving the company additional capital to challenge Illumina in the sequencing market. The company launched ...

Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to ...

Illumina sequencing is renowned for its accuracy, high throughput, and robust infrastructure, while nanopore sequencing stands out for its long read lengths, real-time analysis, and portability.

Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs. Skip to main ...